z-logo
open-access-imgOpen Access
The Clinical Outcomes of Pharmacist Interventions in Total Parenteral Nutrition services in Riyadh City, Saudi Arabia
Author(s) -
Yousef Ahmed Alomi,
Aisha Omar Fallatah,
Nisreen Al-Shubaar,
Abdulaziz Abdullah Qohal,
Lila Yahya Alameer
Publication year - 2019
Publication title -
international journal of pharmacology and clinical sciences
Language(s) - English
Resource type - Journals
ISSN - 2278-0068
DOI - 10.5530/ijpcs.2019.8.23
Subject(s) - medicine , christian ministry , pharmacy , clinical pharmacy , pharmacist , family medicine , hospital pharmacy , psychological intervention , health care , pediatrics , nursing , philosophy , theology , economics , economic growth
Objectives: Total parenteral nutrition (TPN) is the perilous component of nutritional care for neonatal, pediatric and adult patients. TPN is designated for someone who cannot or should not consume nutrients through their regular oral pathway. In this study, we explored the clinical outcomes of pharmacist intervention in Parenteral Nutrition at the public hospital in Riyadh city, Saudi Arabia. Methods: In prospective cohort studies, we simulated the data of 12 months of 2015 related to TPN services for neonatal, pediatric and adult patients. Most of the TPN units at hospitals works eight hours per day and seven days per a week. The hospital in Riyadh, Saudi Arabia has 300 beds. The pharmacist intervention consisted of an International Study Model, measure level of activity, rational of clinical intervention, recommendation, and patient with outcome impact. The data were analyzed through Survey Monkey system. Results: The total number of pharmacist interventions were 402 of recognized TPN-related problems. The total number of TPN orders was 394 prescribed to 82 patients. The majority of patients were neonates 303 (75.56%) followed by Pediatrics 97 (24.19%). The highest number of critical care interventions were found to be potentially serious 108 (28.8%) and potentially significant 174 (46.4%). The documented rationale of clinical intervention activities was inappropriate dose 93 (24.8%) drug therapy omission 50 (13.3%) and inappropriate route of administration 41 (10.9%). Most of the patient outcomes were laboratory value improved 170 (45.33%) and patient condition improved 137 (36.53%). Conclusion: TPN clinical pharmacist had an essential vital role of preventing a TPN-related problem, improve patient outcome, and avoid the unnecessary supplementary cost. Increasing TPN clinical pharmacist assigned for all TPN services at all health care system in Saudi Arabia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom